文献速递胸部肿瘤

miR-758-3p靶向NUSAP1抑制非小细胞肺癌细胞增殖与侵袭

[miR-758-3p inhibits the proliferation and invasion of non-small cell lung cancer cells by targeting NUSAP1].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2021-01-01

该研究在A549非小细胞肺癌细胞中转染miR-758-3p模拟物,通过CCK-8和Transwell实验检测增殖、迁移和侵袭能力,并用双荧光素酶报告基因实验验证靶基因。结果显示miR-758-3p靶向NUSAP1并抑制A549细胞增殖、迁移和侵袭,过表达NUSAP1可逆转上述抑制作用。

要点

  • miR-758-3p模拟物转染A549细胞后显著抑制其增殖、迁移和侵袭。
  • 双荧光素酶实验证实NUSAP1是miR-758-3p的直接靶基因。
  • 过表达NUSAP1可消除miR-758-3p对A549细胞增殖、迁移和侵袭的抑制作用。

核心结论

  • miR-758-3p通过靶向调控NUSAP1基因表达抑制非小细胞肺癌细胞的增殖、迁移和侵袭。

研究设计与样本

  • 体外细胞实验研究,使用人非小细胞肺癌细胞系A549,转染miR-758-3p模拟物、miRNA对照、NUSAP1过表达质粒及miR-758-3p模拟物+NUSAP1共转染。

主要发现

  • 转染24h后,miR-758-3p模拟物组和对照组A549细胞中miR-758-3p相对表达水平分别为3.02±0.16和1.00±0.08,NUSAP1相对表达水平分别为0.04±0.02和1.00±0.03,差异均有统计学意义(均P<0.05)。
  • 转染72h后,miR-758-3p模拟物组和对照组细胞吸光度值分别为0.78±0.06和1.15±0.06,差异有统计学意义(P<0.05)。
  • miR-758-3p模拟物组细胞迁移数为119.04±11.49个,低于对照组的271.38±19.05个(P<0.05);侵袭数为71.33±5.36个,低于对照组的164.30±8.11个(P<0.05)。
  • 双荧光素酶报告基因实验显示,miR-758-3p模拟物转染野生型NUSAP1报告基因的荧光素酶活性为0.37±0.04,低于对照组的1.00±0.03(P<0.05);突变型NUSAP1报告基因和对照组荧光素酶活性分别为0.96±0.02和0.95±0.02,差异无统计学意义(P>0.05)。
  • 过表达NUSAP1可消除miR-758-3p对A549细胞增殖、迁移和侵袭能力的抑制作用。

临床怎么用

  • 该研究为体外细胞水平机制探索,提示miR-758-3p/NUSAP1轴可能成为非小细胞肺癌的潜在研究靶点,尚不能直接指导临床决策。

局限性

  • 研究仅使用A549单一细胞系,缺乏其他NSCLC细胞系及体内动物实验验证。
  • 未在临床样本中检测miR-758-3p和NUSAP1的表达及其与患者预后的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the biological function of miR-758-3p and the underlying mechanism in non-small cell lung cancer (NSCLC). Methods: miR-758-3p mimics was transfected to A549 NSCLC cells, miRNA control was used as a negative control, cells transfected with nucleolar and spindle associated protein 1 (NUSAP1)-overexpression vector indicated as NUSAP1 group, cells co-transfected with miR-758-3p mimics and NUSAP1-overexpression vector indicated as miR-758-3p mimics+ NUSAP1 group. The effects of miR-758-3p on the proliferation, migration and invasion abilities of A549 cells were detected by cell counting kit-8 (CCK-8) and Transwell assays, respectively. Bioinformatics and dual luciferase reporter assay were used to predict and verify the target gene of miR-758-3p. Results: The expressions of miR-758-3p and NUSAP1 in A549 cells were significantly up-regulated at 24 hours after transfection with miR-758-3p mimics (P<0.05). Compared with the miRNA control group (1.15±0.06), the OD value of miR-758-3p mimic group (0.78±0.06) was significantly decreased at 72 hours after transfection (P<0.05). The number of migrated cells of miR-758-3p mimic group (119.04±11.49) was significantly lower than that of the control group (271.38±19.05) (P<0.05). The number of invaded cells of miR-758-3p mimic group (71.33±5.36) was significantly lower than the control group (164.30±8.11) (P<0.05). The result of dual-luciferase reporter assay showed that NUSAP1 was a direct target of miR-758-3p. Moreover, up-regulation of NUSAP1 abolished the inhibitory effects of miR-758-3p on the proliferation, migration and invasion abilities of A549 cells. Conclusion: miR-758-3p inhibits the proliferation, migration and invasion of NSCLC cells by targeting NUSAP1. 目的: 探讨miR-758-3p在非小细胞肺癌(NSCLC)中的生物学功能及其作用机制。 方法: 采用脂质体法转染miR-758-3p模拟物(miR-758-3p模拟物组)、miRNA对照(对照组)、核仁纺锤体相关蛋白1(NUSAP1)过表达质粒(NUSAP1过表达组)、miR-758-3p模拟物+NUSAP1(miR-758-3p模拟物+NUSAP1组)至人NSCLC细胞系A549细胞中。采用CCK-8法和Transwell小室法检测A549细胞增殖、迁移和侵袭能力,结合生物信息学预测网站和双荧光素酶报告基因实验验证miR-758-3p及其靶基因的靶向关系。 结果: 转染24 h后,miR-758-3p模拟物组和对照组A549细胞中miR-758-3p基因的相对表达水平分别为3.02±0.16和1.00±0.08,NUSAP1基因的相对表达水平分别为0.04±0.02和1.00±0.03,差异均有统计学意义(均P<0.05)。转染72 h后,miR-758-3p模拟物组和对照组细胞的吸光度值分别为0.78±0.06和1.15±0.06,差异有统计学意义(P<0.05)。miR-758-3p模拟物组细胞的迁移数和侵袭数分别为[(119.04±11.49)个]和[(71.33±5.36)个],均低于对照组[分别为(271.38±19.05)个和(164.30±8.11)个;均P<0.05]。miR-758-3p模拟物转染野生型NUSAP1报告基因的荧光素酶活性(0.37±0.04)低于对照组(1.00±0.03,P<0.05)。突变型NUSAP1报告基因和对照组的荧光素酶活性分别为0.96±0.02和0.95±0.02,差异无统计学意义(P>0.05)。 结论: miR-758-3p通过调控NUSAP1基因的表达抑制NSCLC细胞的增殖、迁移和侵袭。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li XM, Yu Z, Huai M, et al. [miR-758-3p inhibits the proliferation and invasion of non-small cell lung cancer cells by targeting NUSAP1]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 33472323. doi:10.3760/cma.j.cn112152-20190727-00472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。